ARETERNA

Areterna, a Synthgene Company

@areterna_llc

North Bethesda, Maryland
Biotechnology Research

Overview

About Areterna, a Synthgene Company

Areterna LLC was founded in 2023 as a wholly-owned subsidiary of Synthgene Biotechnology Co., Ltd. to serve customers in the US and Europe.
Synthgene is a company that provides materials and services to support mRNA and oligonucleotide manufacturing. Founded in 2018 by a group of passionate nucleic acid chemists, the goal of the company is to debottleneck the raw material supply and develop innovative solutions to support customers in the industry. The company has a robust quality system and ISO9001 certification to support cGMP manufacturing of mRNA raw materials that include NTPs, modified NTPs and cap analogs. For the GMP raw materials, Drug Master Files have been filed with FDA. In addition, Synthgene offers analytical development service and mRNA-related impurity standards and detection kits, LNP screening service, IVT process development and IVT kits for mRNA research. For solid-phase DNA and RNA synthesis, Synthgene offers high quality phosphoramidites to support cGMP oligo manufacturing. With over 200 scientists in R&D and AI-assisted discovery platform, Synthgene will continue to bring new products to the market.

Headquarters

North Bethesda, Maryland

Website

-

Company Size

201-500 employees

Industry

Biotechnology Research

Company Type

Privately Held

Founded

2023

Specialties

mRNA, Cap Analogs, Enzyme, Nucleotides, Phosphoramidite, Customized Services, Analytical Services, dNTPs, Modified NTPs, Amidites , NTPs, Custom mRNA, and One-pot Co-Transcription kits

Posts